These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
441 related items for PubMed ID: 15780064
1. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A. Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064 [Abstract] [Full Text] [Related]
2. [Analysis of methylation and loss of heterozygosity of RUNX3 gene in hepatocellular carcinoma and its clinical significance]. Xiao WH, Liu WW. Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):227-30. PubMed ID: 15099475 [Abstract] [Full Text] [Related]
3. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma. Long C, Yin B, Lu Q, Zhou X, Hu J, Yang Y, Yu F, Yuan Y. Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463 [Abstract] [Full Text] [Related]
4. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO, Park JG. Oncogene; 2004 Sep 02; 23(40):6736-42. PubMed ID: 15273736 [Abstract] [Full Text] [Related]
5. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Wada M, Yazumi S, Takaishi S, Hasegawa K, Sawada M, Tanaka H, Ida H, Sakakura C, Ito K, Ito Y, Chiba T. Oncogene; 2004 Mar 25; 23(13):2401-7. PubMed ID: 14743205 [Abstract] [Full Text] [Related]
7. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A. Ann Surg Oncol; 2010 Mar 25; 17(3):923-32. PubMed ID: 19898900 [Abstract] [Full Text] [Related]
8. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y. Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857 [Abstract] [Full Text] [Related]
9. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW. Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071 [Abstract] [Full Text] [Related]
10. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. Yanada M, Yaoi T, Shimada J, Sakakura C, Nishimura M, Ito K, Terauchi K, Nishiyama K, Itoh K, Fushiki S. Oncol Rep; 2005 Oct 01; 14(4):817-22. PubMed ID: 16142337 [Abstract] [Full Text] [Related]
11. Frequent inactivation of RUNX3 in endometrial carcinoma. Yoshizaki T, Enomoto T, Fujita M, Ueda Y, Miyatake T, Fujiwara K, Miyake T, Kimura T, Yoshino K, Kimura T. Gynecol Oncol; 2008 Sep 01; 110(3):439-44. PubMed ID: 18572225 [Abstract] [Full Text] [Related]
12. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Sakakura C, Hasegawa K, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yazumi S, Yamagishi H, Okanoue T, Chiba T, Hagiwara A. Clin Cancer Res; 2005 Sep 15; 11(18):6479-88. PubMed ID: 16166423 [Abstract] [Full Text] [Related]
13. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z. Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):831-6. PubMed ID: 19173828 [Abstract] [Full Text] [Related]
14. Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma. Sakai M, Hibi K, Kanazumi N, Nomoto S, Inoue S, Takeda S, Nakao A. Hepatogastroenterology; 2005 Nov 15; 52(66):1854-7. PubMed ID: 16334792 [Abstract] [Full Text] [Related]
15. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G. Gastroenterology; 2008 Dec 15; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366 [Abstract] [Full Text] [Related]
16. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma. Song J, Kim CJ, Cho YG, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS. J Gastroenterol Hepatol; 2006 Aug 15; 21(8):1286-9. PubMed ID: 16872311 [Abstract] [Full Text] [Related]
17. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma. Yeo W, Wong N, Wong WL, Lai PB, Zhong S, Johnson PJ. Liver Int; 2005 Apr 15; 25(2):266-72. PubMed ID: 15780049 [Abstract] [Full Text] [Related]
18. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Ito Y, Chayama K, Yasui W. Pathobiology; 2004 Apr 15; 71(3):137-43. PubMed ID: 15051926 [Abstract] [Full Text] [Related]
19. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI. Gastroenterology; 2010 May 15; 138(5):1898-908. PubMed ID: 20038433 [Abstract] [Full Text] [Related]
20. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY. Oncol Rep; 2006 Feb 15; 15(2):507-11. PubMed ID: 16391877 [Abstract] [Full Text] [Related] Page: [Next] [New Search]